GRO Biosciences
PrivateLast Round
Series B
Jul 19, 2024
Est. Valuation
$90.3M
Total Funding Raised
$88.4M
Company Overview
GRO Biosciences is a biotechnology company that develops enhanced protein therapeutics using genomically recoded organisms to create biologics with non-standard amino acids for improved potency, stability, and targeted delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GRO Biosciences Comparables
Compare GRO Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pearl Bio | 87% | |
| BrickBio, Inc. | 84% | |
| Tektonyx Bio, Inc. | 82% | |
GRO Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 19, 2024 | ||||
| Series A | Nov 3, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Seed | Sep 28, 2017 |
GRO Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series A |
| Access Industries | Series B |
| Digitalis Ventures | Seed, Series A, Series B |
| Innovation Endeavors | Series A, Seed, Series B |
| Atlas Venture | Series B |
| Leaps by Bayer | Series B, Series A |
| Access Biotechnology | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2021
$25M round led by Leaps by Bayer and Redmile Group.
- Sep 15, 2020
$1M grant awarded by the National Science Foundation.
GRO Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GRO Biosciences's valuation, stock price, and market status.